InMode Q3 2026 Revenue Hits $92.1M as Outlook Reaffirmed
InMode reported $92.1 million in GAAP revenue for Q3 2026 and maintained its full-year financial guidance.
Medical technology company InMode Ltd. posted third-quarter 2026 GAAP revenues of $92.1 million, the Israel-based firm announced Wednesday, as it reaffirmed its full-year 2026 financial outlook.
InMode, which trades on the Nasdaq under the ticker INMD and is headquartered in Yokneam, Israel, describes itself as a leading global provider of innovative medical technologies. The quarterly results represent the company's latest financial benchmark in what has been a closely watched period for the minimally invasive aesthetics and medical device sector.
Read more IQSTEL Posts $313M Nine-Month Revenue on 34.5% Organic Growth →
The company's decision to reaffirm its full-year guidance signals management confidence in demand trends through the remainder of 2026, even as the broader medical technology industry continues to navigate macroeconomic pressures and shifting capital equipment spending by healthcare providers.
InMode has built its business around energy-based medical platforms used in surgical and non-surgical procedures. The company's recurring emphasis on reaffirming guidance each quarter underscores its effort to maintain investor confidence amid ongoing scrutiny of growth-stage medtech valuations on public markets.
Continue reading at Earnings for the complete breakdown of InMode's Q3 2026 financial results, including non-GAAP metrics and forward guidance details.